The evidence which has accumulated on the course of agoraphobia challenges the DSM view that phobic avoidance is secondary to panic attacks. In particular, a longitudinal study by Wittchen et al. indicates that agoraphobia, as a diagnostic category, is frequently independent of panic disorder and panic attacks, is unlikely to remit spontaneously and entails compromised quality of life. A staging system of agoraphobia is presented. Panic may ensue in the longitudinal development of agoraphobia, as well as of other anxiety disorders, and be conceptualized as a potential outcome in the course of anxiety, phobias and hypochondriasis as more than a specific disease entity. These recent research findings confirm the clinical observations and phenomenological research of Sir Martin Roth (1917–2006) and call for a reassessment of the concept of neurosis.

Keywords:
Agoraphobia, Prodromal symptoms, Panic disorder, Phobic disorder, Hypochondriasis, Staging, Neurosis
1.
Nemiah JC: Phobic disorder (phobic neurosis); in Kaplan H, Freedman AM, Sadock BJ (eds): Comprehensive Textbook of Psychiatry III, ed 3. Baltimore, Williams & Wilkins, 1980, vol 2, pp 1493–1504.
2.
Marks IM: Fears, Phobias and Rituals. New York, Oxford University Press, 1987, pp 323–361.
3.
Mayer-Gross W, Slater E, Roth M: Clinical Psychiatry. London, Baillière Tindall, 1977.
4.
Roth M: Some recent developments in relation to agoraphobia and related disorders and their bearing upon theories of their causation. Psychiatr J Univ Ottawa 1987;12:150–155.
5.
Roth M, Myers DH: Anxiety neuroses and phobic states. II. Diagnosis and management. Br Med J 1969;i:559–562.
6.
Roth M: Agoraphobia, panic disorder and generalized anxiety disorder. Psychiatr Dev 1984;2:31–52.
7.
Klein DF: Anxiety reconceptualized; in Klein DF, Rabkin J (eds): Anxiety: New Research and Changing Concepts. New York, Raven Press, 1981.
8.
Roth M, Barnes TRE: The classification of affective disorders: a synthesis of old and new concepts. Compr Psychiatry 1981;22:54–77.
9.
Wittchen HU, Nocon A, Beesdo K, Pine DS, Hofler M, Lieb R, Gloster AT: Agoraphobia and panic: prospective-longitudinal relations suggest a rethinking of diagnostic concepts. Psychother Psychosom 2008;77:147–157.
10.
Bienvenu OJ, Onyike CU, Stein MB, Chen LS, Samuels J, Nestadt G, Eaton WW: Agoraphobia in adults: incidence and longitudinal relationship with panic. Br J Psychiatry 2006;188:432–438.
11.
Eaton WW, Keyl PM: Risk factors for the onset of diagnostic interview schedule/DSM III agoraphobia in a prospective, population-based study. Arch Gen Psychiatry 1990;47:819–824.
12.
Thompson AH, Bland RC, Orn HT: Relationship and chronology of depression, agoraphobia and panic disorder in the general population. J Nerv Ment Dis 1989;177:456–463.
13.
Fava GA, Mangelli L: Subclinical symptoms of panic disorder. Psychother Psychosom 1999;68:281–289.
14.
Fava GA, Grandi S, Canestrari R: Prodromal symptoms in panic disorder with agoraphobia. Am J Psychiatry 1988;145:1564–1567.
15.
Fava GA, Grandi S, Rafanelli C, Canestrari R: Prodromal symptoms in panic disorder with agoraphobia: a replication study. J Affect Disord 1992;26:85–88.
16.
Garvey MJ, Cook B, Noyes F: The occurrence of prodrome of generalized anxiety in panic disorder. Comp Psychiatry 1988;29:445–449.
17.
Lelliott P, Marks I, McNamee G, Tobena A: Onset of panic disorder with agoraphobia. Arch Gen Psychiatry 1989;46:1000–1004.
18.
Argyle N, Roth M: The phenomenological study of 90 patients with panic disorder. Part II. Psychiatr Dev 1989;3:187–209.
19.
Fava GA, Grandi S, Saviotti FM, Conti S: Hypochondriasis with panic attacks. Psychosomatics 1990;31:351–353.
20.
Perugi G, Toni C, Benedetti A, Simonetti B, Simoncini M, Torti C, Musetti L, Akiskal HS: Delineating a putative phobic-anxious temperament in 126 panic-agoraphobia patients. J Affect Disord 1998;47:11–23.
21.
Faravelli C, Pallanti S, Biondi F, Paternità S, Scarpato MA: Onset of panic disorder. Am J Psychiatry 1992;149:827–828.
22.
Furlong FW: Antecedents of ‘spontaneous’ panic attacks (letter). Am J Psychiatry 1989;146:560.
23.
Fava GA, Kellner R: Staging. A neglected dimension in psychiatric classification. Acta Psychiatr Scand 1993;87:225–230.
24.
Hetrick SE, Parker AG, Hickie I, Purcell R, Yung A, McGorry PD: Early identification and intervention in depressive disorders: towards a clinical staging model. Psychother Psychosom, in press.
25.
Fava GA, Tomba E, Grandi S: The road to recovery from depression. Psychother Psychosom 2007;76:260–265.
26.
Battaglia M, Bertella, Bajo S, Binaglia F, Bellodi L: Anticipation of age of onset in panic disorder. Am J Psychiatry 1998;155:590–594.
27.
Saviotti FM, Grandi S, Savron G, Ermentini R, Bartolucci G, Conti S, Fava GA: Characterological traits of recovered patients with panic disorder and agoraphobia. J Affect Disord 1191;23:113–117.
28.
Mavissakalian M, Hamam MS: DSM-III personality characteristics of panic disorder with agoraphobia patients in stable remission. Compr Psychiatry 1992;33:305–309.
29.
Ryff CD, Dienberg Love G, Urry HL, Muller D, Rosenkranz MA, Friedman EM, Davidson RJ, Singer B: Psychological well-being and ill-being. Psychother Psychosom 2006;75:85–95.
30.
Pasquali R: The biological balance between psychological well-being and distress. Psychother Psychosom 2006;75:69–71.
31.
Schubert C: Psychological well-being and ill-being and their biological correlates. Psychother Psychosom 2007;76:252–253.
32.
Joseph S: Is the CES-D a measure of happiness? Psychother Psychosom 2007;76:60.
33.
Ryff CD, Singer B: What to do about positive and negative items in studies of psychological well-being and ill-being? Psychother Psychosom 2007;76:61–62.
34.
Fava GA, Rafanelli C, Ottolini F, Ruini C, Cazzaro M, Grandi S: Psychological well-being and residual symptoms in remitted patients with panic disorder and agoraphobia. J Affect Disord 2001;65:189–190.
35.
Bruckl TM, Wittchen HU, Hofler M, Pfister H, Schneider S, Lieb R: Childhood separation anxiety and the risk of subsequent psychopathology. Psychother Psychosom 2007;76:47–56.
36.
Servant D, Bailly D, Allard C, Parquet PJ: Major depression in panic disorder: role of recent life events. J Affect Disord 1991;22:79–82.
37.
Fava GA, Kellner R, Zielezny M, Grandi S: Hypochondriacal fears and beliefs in agoraphobia. J Affect Disord 1988;14:239–244.
38.
McNally RJ, Lorenz M: Anxiety sensitivity in agoraphobia. J Behav Ther Exp Psychiatry 1987;18:3–11.
39.
Noyes R, Reich J, Clancy J, O’Gorman TW: Reduction of hypochondriasis with treatment of panic disorder. Br J Psychiatry 1986;149:631–635.
40.
Detre TP, Jarecki HG: Modern Psychiatric Treatment. Philadelphia, Lippincott, 1971.
41.
Rifkin A, Pecknold JC, Swinson RP, Ballenger JC, Burrows GD, Noyes R, Dupont RL, Lesser I: Sequence of improvement in agoraphobia with panic attacks. J Psychiatr Res 1990;24:1–8.
42.
Fava GA, Grandi S, Canestrari R, Grasso P, Pesarin F: Mechanisms of change of panic attacks with exposure treatment of agoraphobia. J Affect Disord 1991;22:65–71.
43.
Deltito JA, Argyle N, Buller R, Nutringer D, Ottosson JO, Brandon S, Mellergard M, Shera D: The sequence of improvement of the symptoms encountered in patients with panic disorder. Compr Psychiatry 1991;32:120–129.
44.
Fava GA, Zielezny M, Savron G, Grandi S: Long-term effects of behavioural treatment for panic disorder with agoraphobia. Br J Psychiatry 1995;166:87–92.
45.
Fava GA, Kellner R: Prodromal symptoms in affective disorders. Am J Psychiatry 1991;148:823–830.
46.
Dusseldorp E, Spinhoven P, Bakker A, van Dyck R, van Balkom AJLM: Which panic disorder patients benefit from which treatment. Psychother Psychosom 2007;76:154–161.
47.
Heldt E, Blaya C, Isolan L, Kipper L, Teruchkin B, Otto MW, Fleck M, Manfro GG: Quality of life and treatment outcome in panic disorder. Psychother Psychosom 2006;76:183–186.
48.
Baer L, Greist J, Marks IM: Computer-aided cognitive behaviour therapy. Psychother Psychosom 2007;76:193–195.
49.
Sonino N, Fava GA: Rehabilitation in endocrine patients. Psychother Psychosom 2007;76:319–324.
50.
Maj M: Are we able to differentiate between true mental disorders and homeostatic reactions to adverse life-events? Psychother Psychosom 2007;76:257–259.
51.
Cosgrove L, Krimsky S, Vijaraghavan M, Schneider L: Financial ties between DSM-IV panel members and the pharmaceutical industry. Psychother Psychosom 2006;75:154–160.
52.
Fava GA: A different medicine is possible. Psychother Psychosom 2006;75:1–3.
53.
Heath I: Combating disease mongering. PLoS Med 2006;3:e146.
54.
Fava GA: The concept of neurosis: a reassessment is overdue. Psychother Psychosom 1993;59:113–114.
55.
Slater E, Slater P: A heuristic theory of neurosis. J Neurol Psychiatry 1944;7:49–55.
56.
Slater E: The neurotic constitution. J Neurol Psychiatry 1943;6:1–16.
57.
Mayer-Gross W, Moore JNP, Slater P: Forecasting the incidence of neurosis in officers of the army and the navy. J Ment Sci 1949;95:80–100.
58.
Sims ACP: Neurotic illness: conserving a threatened concept. Br J Clin Pharmacol 1985;19:S9–S15.
59.
Snaith P: Clinical Neurosis. Oxford, Oxford University Press, 1991.
60.
Tyrer P, Seivewright N, Fuguson B, Tyrer J: The general neurotic syndrome. Acta Psychiatr Scand 1992;85:201–206.
61.
Engel GL: Physician-scientists and scientific physicians. Am J Med 1987;82:107–111.
62.
Rothwell PM: Medical academia is failing patients and clinicians. BMJ 2006;332:863–864.
63.
Fava GA: The intellectual crisis of psychiatric research. Psychother Psychosom 2006;75:202–208.
64.
Wise TN: Curiosity and crisis. Psychother Psychosom 2006;75:199–201.
65.
Kerr A, Kay D: Sir Martin Roth FRS. An appreciation. Br J Psychiatry 2007;190:375–378.
66.
Bech P: The full story of lithium. A tribute to Mogens Schou (1918–2005). Psychother Psychosom 2006;75:265–269.
67.
De Figueredo JM: Demoralization and psychotherapy. A tribute to Jerome D. Frank, MD, PhD (1909–2005). Psychother Psychosom 2007;76:129–133.
68.
Falloon IRH: Antipsychotic drugs: when and how to withdraw them? Psychother Psychosom 2006;75:133–138.
69.
Balon R: Reflections on relevance: the fields of psychosomatics and psychotherapy in 2005. Psychother Psychosom 2006;75:5–11.
70.
Balon R: Reflections on relevance: the fields of psychosomatics and psychotherapy in 2006. Psychother Psychosom 2007;76:203–212.
© 2008 S. Karger AG, Basel
2008
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.